Riskpilot← Back to searchSign inGet full accessPEAK BIOTECH A/S
A/SActiveCVR 28892152Bøgeskovvej 18AManufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 20058 employees
Revenue 2025
DKK 29,4M
+31% vs 2024
EBITDA margin
94.0%
+32% vs 2024
Equity ratio
46.6%
Financial strength
Net profit 2025
DKK 21,9M
+32% vs 2024
| Revenue | DKK 29,4M | +31% |
| EBITDA | DKK 27,7M | +32% |
| Net profit | DKK 21,9M | +32% |
| Total assets | DKK 94,5M | +94% |
| Equity | DKK 44M | +99% |
| Employees | 8 | — |
Legal name
PEAK BIOTECH A/S
CVR number
28892152
Legal form
Aktieselskab
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
11. juli 2005
Share capital
DKK 600.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med rådgivning og produktion af udstyr til farmaceutisk og bioteknisk industri og dermed forbundet virksomhed.
Address
Bøgeskovvej 18A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.859 | 2.054 | 1.890 | 1.346 | 6.203 | 7.692 | 6.752 | 10.500 | 10.434 | 9.118 | 8.782 | 8.045 | 22.439 | 29.438 |
| Staff expenses | -1.265 | -1.409 | -1.405 | -1.659 | -1.671 | -1.754 | -2.207 | -2.247 | -2.449 | -2.477 | -2.369 | -3.114 | -0 | -0 |
| EBITDA | 594 | 645 | 486 | -313 | 4.533 | 5.938 | 4.545 | 8.253 | 7.985 | 6.641 | 6.413 | 4.930 | 21.034 | 27.684 |
| Depreciation & amort. | -39 | -9 | -0 | -40 | -40 | -40 | -40 | -40 | -0 | -0 | -0 | -4 | -0 | -0 |
| EBIT | 555 | 636 | 486 | -353 | 4.493 | 5.898 | 4.505 | 8.213 | 7.985 | 6.641 | 6.413 | 4.927 | 21.034 | 27.684 |
| Net financials | 56 | -57 | 6 | -71 | -57 | -37 | -42 | -73 | -88 | -105 | -351 | -597 | 131 | 346 |
| Profit before tax | 611 | 579 | 492 | -424 | 4.435 | 5.861 | 4.463 | 8.140 | 7.897 | 6.536 | 6.061 | 4.330 | 21.165 | 28.030 |
| Tax | 177 | 144 | 123 | -99 | 982 | 1.293 | 984 | 1.800 | 1.738 | 1.439 | 1.346 | 955 | 4.658 | 6.169 |
| Net profit | 435 | 434 | 369 | -325 | 3.453 | 4.568 | 3.479 | 6.340 | 6.159 | 5.097 | 4.715 | 3.374 | 16.506 | 21.861 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.777 | 6.248 | 5.452 | 9.010 | 12.919 | 14.979 | 13.253 | 17.018 | 20.291 | 14.151 | 27.130 | 45.755 | 48.719 | 94.508 |
| Equity | 3.864 | 3.998 | 4.067 | 3.442 | 6.895 | 8.463 | 7.441 | 10.281 | 10.440 | 11.038 | 10.653 | 13.577 | 22.133 | 43.994 |
| Long-term debt | 187 | 155 | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 727 | 2.095 | 1.299 | 5.568 | 6.024 | 6.516 | 5.811 | 6.737 | 9.851 | 3.113 | 16.478 | 32.171 | 26.574 | 50.513 |
| Total debt | 914 | 2.250 | 1.385 | 5.568 | 6.024 | 6.516 | 5.811 | 6.737 | 9.851 | 3.113 | 16.478 | 32.171 | 26.574 | 50.513 |
EBITDA margin
94.0%
This company
15.8%
Market median
+495% vs market
20122025
Equity ratio
46.6%
This company
38.2%
Market median
+22% vs market
20122025
Return on equity
49.7%
This company
18.4%
Market median
+170% vs market
20122025
Net profit margin
74.3%
This company
8.1%
Market median
+817% vs market
20122025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20122025
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KG Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PEAK HOLDING ApS | Company | 66.7% | 66.7% | 2009 |
BIOTECH HOLDING ApS | Company | 33.3% | 33.3% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOTECH HOLDING ApS
PEAK BIOTECH A/S Board members of PEAK BIOTECH A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Gejl Vind | Chief Executive Officer | 0 companies |
| Jesper Engesgaard | Board of Directors | 0 companies |
| Lars Anders Almblom Jørgensen | Board of Directors | 0 companies |
| Jens Ulrik Damgaard | Chairman | 0 companies |
| Jacob Nøhr | Board of Directors | 0 companies |
| Jan Pojezny | Board of Directors | 0 companies |
| Lars Harding Knudsen | Chairman | 0 companies |